Dr. David Lee, M.D.
Neurology (Epilepsy Physician)
9350 Campus Point Dr
La Jolla, CA 92037
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 221
Licensed in California since 2013, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Epilepsy Physician primary
CA license A124329 (first issued 2013; current) -
Neurology Physician
CA license A124329 (first issued 2013; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UC San Diego Health Hillcrest - Hillcrest Med Ctr San Diego, CA
Medical groups
- Regents of the University of California (2,089 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 221
- Services billed
- 548
- Patients’ average age
- 65
| Service | Times | Patients |
|---|---|---|
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 129 | 60 |
| Established patient office or other outpatient visit, 40-54 minutes | 64 | 43 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 55 | 52 |
| Established patient office or other outpatient visit, 30-39 minutes | 35 | 28 |
| Measurement of brain wave activity (eeg), awake and drowsy | 31 | 31 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 27 | 11 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 26 | 12 |
| Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | 15 | 15 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 13 | 13 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levetiracetam Other prescribers in La Jolla, CA | 301 |
| Lamotrigine Other prescribers in La Jolla, CA | 125 |
| Topiramate Other prescribers in La Jolla, CA | 109 |
| Phenobarbital Other prescribers in La Jolla, CA | 98 |
| Oxcarbazepine Other prescribers in La Jolla, CA | 92 |
| Lacosamide Other prescribers in La Jolla, CA | 85 |
| Aptiom (eslicarbazepine acetate) | 78 |
| Zonisamide Other prescribers in La Jolla, CA | 67 |
| Gabapentin Other prescribers in La Jolla, CA | 65 |
| Carbamazepine Er (carbamazepine) Other prescribers in La Jolla, CA | 49 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $19.62 in total to this clinician.
| Acadia Pharmaceuticals Inc | $19.62 |
|---|
| Food and Beverage | $19.62 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,014 in research payments for these studies, mostly to the institutions running them.
- Cenobamate Open-Label Extension Study for YKP3089C025
Sk Life Science, Inc. · Completed · NCT03961568
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.